Swedish Orphan Biovitrum AB (Sobi) has jumped on the mergers and acquisition merry-go-round to acquire Dova Pharmaceuticals Inc., expanding its hematology franchise and commercial presence in the US.
Described by CEO Guido Oelkers as "a marriage made in heaven," the acquisition gives Sobi control of Dova ’s oral...








